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Abstract
Background: Transgender and Gender-Nonconforming (TGNC) populations comprise
approximately 6% of the U.S. population. Socially and within the medical treatment system
TGNC individuals face widespread stigmatization and discrimination which negatively impacts
their mental, physical, and emotional health and contributes to health disparities. Real and
perceived barriers to safe and effective healthcare are worsened by the scarcity of primary care
providers knowledgeable in caring for these populations
Objectives: The aim of this quality improvement project was to examine the impact of inclusive
gender-affirming integration on the utilization of preventive and primary care services.
Methods: A one group pre- and post-intervention design was used to measure utilization of
preventive and primary care services prior to and following integration of inclusive and
affirming care. The Chi-Square Test of Associations (X²) analysis was performed for the project
aim.
Results: Results revealed a correlation between integration of inclusive and affirming services
and tobacco use screening (p<0.001), cervical cancer screening (p=0.022), BMI screening
(p<0.001), and HIV screening (p=0.212). Screening rates that noted a small negative correlation
to integrating gender-affirming services into primary care: Depression screening (p<0.001;
X²=64.518; PHI=-0.250) and HTN screening (p=0.240, X²=1.378, Phi=-0.036)
Conclusion: Results of this project successfully noted that four of the six preventive health
screenings showed a positive association between the integration of inclusive gender-affirming
services into primary care and did affect the rate at which preventive screenings were utilized by
TGNC patients accessing primary care services. More significantly, the project also revealed a
significant increase of TGNC patients seeking care.
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Improving Primary Care Utilization for Transgender Patients at an FQHC
Background
Approximately 1.4 million or 6% of Americans identify as transgender (Flores, Herman,
Gates, & Brown, 2016). The transgender population in the US is likely much higher; however,
methods for collecting gender identity data are still evolving and unreliable (Hoffman, 2016).
The term transgender (TG) is used to describe individuals whose internal gender identity does
not align with their assigned sex at birth, whereas individuals who are cis-gender have a gender
identity aligning with their birth-assigned sex. Gender non-conforming (GNC) describes
individuals whose gender expression does not follow the society norms associated with the
gender binary of masculinity and femininity (Selix & Rowniak, 2016). For this project TG and
GNC will be referred to as TGNC.
TGNC individuals face discrimination, humiliation, and abuse at every level of their
lives, including rejection and abuse from family, denial of employment, public
criticism/victimization, and denial of care in medical settings. These chronic stressors negatively
impact the physical, social, and emotional health of this population (Radix, Lelutiu-Weinberger,
& Gamarel, 2014). For example, TGNC individuals use negative coping responses such
substance abuse, including injecting drugs to manage the social and economic stress associated
with transphobia (Radix et al., 2014, p. 303). The health disparities that TGNC individuals
experience due to discrimination and social/internal stigmatization, also affects the ability for
these individuals to seek safe and effective healthcare (Cruz, 2014). Several studies have
reported that stigma influences access and healthcare utilization among vulnerable populations,
gender minorities such as TGNC populations, are disproportionately impacted (Whitehead,
Shaver, & Stephenson, 2016) (Radix et al., 2014) (Reisner et al., 2015). The largest transgender
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study to date, the 2008-2009 National Transgender Discrimination Survey, reported that
approximately 22% of gender diverse people have been refused care at healthcare facilities and
66% postponed needed care due to lack of knowledgeable healthcare providers and fear of
discrimination or abuse by providers and healthcare staff (Thompson, 2016). Subsequently,
TGNC individuals encounter many barriers when seeking healthcare services that lead to subpar
care, including late or inadequate diagnoses of disease.
To date research regarding the morbidity and mortality rates, the utilization of primary
care, and health outcomes of gender diverse populations has been limited. However, several
studies have noted that TGNC populations have a higher prevalence of tobacco use, substance
use, mental health issues, obesity, diabetes, heart disease, HIV, and sexually transmitted
infections (STIs) than the general population (Feldman et al., 2016) (Radix et al., 2014)
(Melendez & Pinto, 2009). Addressing the intersecting layers of health disparities for this
population is made especially difficult given the scarcity of safe, gender-affirming, and
competent care. The lack of these resources coupled with real and perceived discrimination
increases this population’s risk for poor health outcomes. Healthcare facilities that serve lesbian,
gay, bisexual (LGB) populations may provide care to TGNC patients. However, accessing a
healthcare facility that serves primarily LGBT patient populations may create yet another barrier
for the gender diverse populations seeking care (Bauer, Zong, Scheim, Hammond, & Thind,
2015). One qualitative study noted that TGNC individuals often feel disconnected to the LGB
community which could lead to TGNC patients not seeking care at these healthcare facilities
(Melendez & Pinto, 2009). In healthcare systems that do serve TGNC patients regularly, care is
segmented. For instance, patients may receive primary care at one facility, but may have to
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receive gender-affirming care, such as cross-sex hormone therapy, at another facility. Segmented
care increases barriers which may lead to negative health outcomes.
In addition to medical care needed to support transition, TGNC individuals have primary
and preventive health care needs that are much like that of the general population. Seeking
regular preventive healthcare can minimize health disparities and related costs associated with
treating advanced illnesses in this population. Primary care is a well-suited option to provide the
TGNC populations with holistic care that encompasses much needed preventive, primary, and
transgender-related care. One way in which health disparities can be eliminated and access to
care increased in this population is to integrate comprehensive care, gender-affirming care into
primary care settings.
Problem Statement
The TGNC populations in the U.S. encounter many barriers such as stigma and
discrimination, which diminish their access and utilization to care. These disparities are
worsened by the scarcity of primary care providers knowledgeable in caring for this population.
Purpose
Using a one group pre- and post-test design, this quality improvement project conducted
at Outside In, a Federally Qualified Healthcare Center (FQHC) in Portland, Oregon examined
the impact of integrating transgender health services into primary care on the utilization of
primary care for its TGNC population. This was achieved by looking at the rate of six preventive
health screenings for TGNC patients at a federally qualified healthcare center (FQHC) and the
rate of growth of this population over a four-year span.
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Specific Aim
The TGNC populations are considered vulnerable and marginalized populations that
require gender-affirming care related to gender dysphoria or gender incongruence experienced
by TGNC patients. Gender-affirming care may encompass the following: hormone therapy,
surgery, facial hair removal, interventions for voice modification, behavioral health services that
may provide letters needed for surgery, and behavioral adaptions such as genital tucking,
packing, or chest binding (University of California, San Francisco [UCSF], 2017, para. 1). It’s
important to note that not all TGNC patients will seek any or all the above-mentioned services.
Providing comprehensive care to this population should include gender-affirming care coupled
with primary care services that provide preventive healthcare, also known as gender-affirming
primary care and should be the gold standard of care for treating all TGNC patients
The specific aim of this quality improvement project was to compare the impact to an
FQHC’s TGNC population prior to and after the integration of inclusive gender-affirming
services into its existing primary care services from a standalone monthly transgender clinic.
This was accomplished by looking at the rates of six US Preventive Services Task Force
(USPTF), Center for Disease Control (CDC), and the Center for Excellence for Transgender
Health recommended preventive health screenings (cervical cancer screening, depression
screening, Body Mass Index (BMI) screening, HIV screening, hypertension (HTN) screening,
and tobacco use screening) for all patients with a gender dysphoria/gender identity/gender
incongruence/trans-male-to-female/trans female-to-male/endocrine dysfunction diagnoses and
indicating a gender different than assigned sex at birth in the electronic health record (EHR).
The pool of patients fitting the gender and diagnosis inclusive criteria also accessed care two
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years prior to integration of gender-affirming services into primary care thru two years post
integration (July 1, 2013 to June 30, 2017).
See Table 1. Identifying and Defining Variables
Project Aims
The aim of the project is to identify clinical practices and guidelines that can be enhanced
through quality improvement efforts for TGNC patients accessing healthcare at Outside In. In
particular, this project aims to identify areas of improvement related to rates of cervical cancer
screening, depression screening, BMI, HTN, HIV, and tobacco use screening among transgender
and gender non-conforming people receiving care at Outside In.
Significance
With the implementation of the Affordable Care Act of 2010, which banned sex
discrimination in healthcare facilities that received Federal funding, and the increased visibility
of transgender narratives in mainstream media - TGNC populations have gained greater social
acceptance (Selix & Rowniak, 2016). Still unclear, is the extent to which the healthcare needs of
TGNC populations are unmet (Roberts & Fantz, 2014).
Nurses and Advanced Practice Nurses (APNs) are well suited to champion the rights of
the most vulnerable populations. The American Nurses Association (ANA) notes in its Code of
Ethics that a nurse’s practice must be carried out with respect, integrity, and with an eye in
preserving the dignity of every person (ANA, 2017). Nurses are responsible for advancing the
practice of nursing by utilizing evidence-based research in the development of professional
standards of care (ANA, 2017). It is this unique training and perspective that will improve the
health outcomes and advance the research needed to alleviate the health disparities of the TGNC
populations (Biederman & Hines, 2016). As noted previously, TGNC health research is
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desperately lacking in all areas. This project will expand the state of the science in TGNC health,
inform primary care practice changes, guide development of standards for health promotion and
gender affirming care, and improve the health outcomes for TGNC individuals.
Literature Review
The estimated TGNC populations in the U.S. is approximately 0.3% to 0.5%, however
this estimate may be lower than true numbers due to inadequacies in the collection of
demographic data of these populations (Sedlak, Veney, & O’Bryan Doheny, 2016). Gender
diverse individuals experience many barriers to quality healthcare, including social and
institutional stigma, discrimination, and being refused healthcare because of their gender
identity. Collectively, these structural barriers have created systemic avoidance of mainstream
healthcare (Poteat, German, & Kerrigan, 2013).
Fear of discrimination from the healthcare community is a commonly reported barrier to
healthcare seeking in TGNC people. In a cross-sectional study of gender-affirming services
conducted in Canada, 83.1% of 433 gender diverse patients surveyed reported feeling
uncomfortable discussing TG related issues with their family practice provider (Bauer, et al.,
2015). Provider attitude, lack of knowledge about TG healthcare, and ambivalence towards
TGNC individuals have been reported as additional barriers to care (Bauer et al., 2015; Jaffee,
Shires, & Stroumsa, 2016; & Whitehead et al., 2016).
Clinical uncertainty and ambivalence regarding care of TG individuals have also been
reported in studies that examined the medical providers’ perspective. A grounded theory study
that specifically examined stigma within the context of healthcare interactions, revealed that
providers lack the requisite medical training, and thus certainty, that is needed to provide
comprehensive care n TG people (Poteat et al., 2013). Medical provider uncertainty coupled with
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internalized stigma in the TGNC patient, shifts the power in the patient-provider relationship in
favor of the provider (Poteat et al., 2013). This power shift may increase the patient’s feelings of
discrimination and stigmatization and discourage them from accessing healthcare. Feelings of
uncertainty and ambivalence are not unique to medical providers. For instance, other studies
have revealed that support staff may respond in similarly discriminatory fashion (Lindroth,
2016). Ensuring that providers and support staff have appropriate education in TG health and
cultural humility/diversity is a critical step in facilitating safe and affirming care for gender
diverse individuals and decreasing the re-traumatization that occurs when TGNC patients seek
healthcare.
Prior studies have shown that the health care needs for TGNC patients far exceed that of
cross-sex hormone therapy (Selix & Rowniak, 2016). For example, a study conducted in the
Canadian health system revealed that despite facing some discomfort in discussing trans health
issues, most gender-affirming care is being performed at the family practice level (Bauer et al.,
2015). Additionally, most experts in TG health note that the bulk of transgender health related
services, including cross-sex hormone therapy, can be successfully managed within a primary
care setting (Wylie et al., 2016). Mainstreaming TG specific needs into primary care provides an
opportunity to expand TGNC’s access to comprehensive care, including preventive care and
chronic disease management (Selix & Rowniak, 2016). Primary care providers (PCP) are well
suited for managing the increased health disparities experienced by gender diverse populations.
For instance, PCPs can manage hormone therapy and facilitate referrals to specialty services
(Bauer et al., 2015). Despite this potential, PCPs and other medical staff, lack the education and
training needed to provide competent care to this population.
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There is some empirical evidence which suggests that TGNC people prefer bundled care
services, e.g. “one-stop shopping,” receiving care at the community health clinic instead of the
LGBT clinic; and prefer accessing care at an affirming and safe environment (Melendez & Pinto,
2009). However, studies on the effectiveness of providing care to gender diverse populations in
primary, specialty, and mental health care settings are limited. More work needs to be done to
ensure that primary care practices can provide a safe and affirming place for TGNC individuals
to receive quality and patient-centered care.
Theoretical Foundation
The Minority Stress Theory (MST) provides an organizing lens for this study. MST, is an
expansion of the Social Stress Theory, describing a relationship between minority and dominant
values and the conflict that results within the social environment and experienced by minority
groups (Meyer, 2013, p. 4). The MST’s underlying assumptions: Stress is unique among
stigmatized individuals, is chronic due to the social and cultural structures in place, and is
socially based due to ingrained social processes, institutions, and structures (Meyer, 2013, p. 4).
Myer further narrows the focus of the MST to describe minority stress processes in the sexual
and gender minority populations. Meyer’s MST identifies experiences of prejudices, rejections,
concealment of sexual/gender minority status, and internalized homophobia/transphobia
stigmatization as indicators of poor mental and physical health outcomes (Tebbe & Moradi,
2016). Thus, the MST provides a framework for understanding how removal of structural
barriers within healthcare institutions through the adoption and integration of inclusive genderaffirming care into a primary care clinic influences the uptake of primary medical services
among transgender patients at Outside In.
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Figure 1. Minority stress processes in lesbian, gay, and bisexual populations (Meyer, 2013).

The MST provided the foundation for this study, which aimed to examine utilization of
primary care and gender-affirming services in an inclusive and safe environment among TGNC
individuals
Methods
Research Design and Population:
This Quality Improvement project used a one group pre- and post-intervention design. In
the one group, pre- and post-test design, subjects are selected (TGNC patients at Outside In), a
manipulation is introduced (implementation of inclusive care), and the behavior or dependent
variable (screening rates) is measured. The project looked at the impact of primary care
utilization of TGNC patients prior to and following the integration of the Transgender Clinic into
Primary Care Clinical Services on July 1, 2015 at Outside In, a Federally Qualified Health
Center (FQHC). Data was collected retrospectively from two EHRs. This project looked at data
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collected from the GE Centricity system from July 1, 2013 to June 5, 2015 and data collected
from OCHIN Epic system from June 6, 2015 to June 30, 2017.
This project design enabled the researcher to complete the project, which had a limited time scope,
and the number of patient encounters was pre-determined within the EHR.
Included in this quality improvement project were patients who: were 18 years of age or
older, had a medical appointment with a medical provider at Outside In least once from July 1,
2015 to June 30, 2017, and who had any of the following diagnostic codes:
•

ICD-9 codes (256.39, 257.2, 259.9, 302.0, 302.3, 302.5, 302.50-53, 302.85, 302.89,
302.9, 309.9, 752.7)

•

ICD-10 codes (E28.39, E29.1, E34.9, E43.20, E52.9, F64, F64.0, F64.1, F64.8, F64.9,
F65.1, F65.81, F66, Q56.3, Q56.4, Z87.890)

•

Modifier codes 45 and/or kx, a gender (M, F, FtoM, MtoF, and Other) that differs from
birth sex.

See Table 2. Inclusive Codes for a definition of ICD-9/ICD-10codes.
Setting:
The project was conducted at Outside In, a Federally Qualified Health Clinic (FQHC)
located in downtown Portland, Oregon or at one of the clinic’s mobile medical vans. All EHRs
from July 1, 2013 to June 30, 2017 of patients who met the inclusive criteria were examined.
Instrumentation/Measurements:
Data were abstracted retrospectively from two EHRs, GE Centricity and OCHIN Epic.
Four data abstraction tools were utilized to collect data:
1) Structured Query Language (SQL): SQL is the computer standard language that is used to
store, manipulate, and query data. It is the standard language that is used to abstract data from
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Relational Database Management Systems (RDMS), such as EHRs (SQL, 2017). This reporting
tool was used to abstract data from the GE Centricity platform.
2) Crystal Reports: A business intelligence application that is used to design and generate
reports from a wide range of data sources (“Crystal Reports”, 2017). The application supports
effective selection and linkage of tables in RDMS. This data abstraction tool was specifically
used to abstract data from the GE Centricity platform.
3) Business Objects Report Tools: A reporting deployment platform that provides reporting, data
visualization, and predictive analytics (http:www.autimatic.com/busines-objects-reporting.com).
4) A data abstraction tool was specifically used to abstract data from OCHIN, an offsite database
operated by OCHIN and connected to Outside In’s OCHIN Epic EHR. See Appendix for the data
collection tool-also name your tool.
Data Collection Procedures and Timeline:
Data was collected from OCHIN Epic’s EHR database by the members of the Data &
Reporting team at Outside In. Prior to data abstraction, a coding manual which served as a
reference tool for both data abstractors was developed.
Two expert data abstractors collected data from the EHRs. Additional training in data
reporting was not required for this project. To reduce bias, only the researcher had knowledge of
and access to the purpose and aim of this project
Data Analysis Plan
SPSS 25 was utilized to store and analyze all data.
•

Data was downloaded from Excel to SPSS 25 by the researcher.

•

Descriptive statistics was performed on categorical variables and frequency and
percentage are reported.
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The Chi-Square Test of Associations (X²) analysis was performed for the project aim identify areas of improvement related to rates of cervical cancer screening, depression
screening, BMI Screening, HTN screening, HIV screening, and tobacco use screening
among transgender and gender non-conforming people receiving care at Outside In.

Ethical Considerations
Data for this project was abstracted and stored onsite at Outside In. All data was stored
on Outside In’s server under a password-protected file; only the researcher had access to the
password. All EHR charts included in the study were assigned a unique identifying number.
Identifying patient information (Names, medical record numbers) were then cross-referenced
with the unique identifier and kept separately from the abstracted data in a separate password
protected file on Outside In’s server. De-identified data will be maintained for a minimum three
years to allow time for dissemination of work and publications. After three years the IT team will
delete all data collected from the chart. All Outside In staff who participated in the abstraction
and review of data completed HIPAA training at Outside In and were aware of confidentiality
requirements in working with patient data.
Results
Patient Population
A total of 1,035 TGNC patients, representative of the entire TGNC identified patients served at
Outside In over a four-year span and who met the inclusive criteria, were included in this project.
The most significant change noted in the demographic data was an increase from 175 (17%)
TGNC patients meeting the inclusive criteria to 860 (83%) TGNC patients who met the inclusive
criteria of this project. This increase represents a 66% increase of TGNC patents who met the
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inclusive criteria of this study and who received care at Outside In after integrating genderaffirming health services into primary care services.
See Table 3. Population Characteristics Pre- and Post-Integration.
Birth-Sex & Gender Identity
Results also revealed an increase of patients who were biologically male (5.5%) and a
decrease (5.5%) in biologically female patients post-integration of services. Patients choosing to
use non-binary pronouns (They/Them) also increased (8.9%) while the male binary pronoun saw
a decrease (16.8%) post-integration of services.
Age
The largest age group observed was 20-29 years. Post-integration TGNC patients 18-19
years of age decreased by 5% while patients in the 30-39 age group increased by 5%.
Race/Ethnicity
White/Caucasian Non-Hispanic TGNC patients meeting inclusive criteria for this project
saw an increase from 199 (68%) patients pre-integration to 650 (76%) patients post-integration.
Asian TGNC patients meeting inclusive criteria for this project saw an increase from 3 (2%)
patients pre-integration to 68 (8%) patients post-integration.
Insurance Status
Insurance status saw a dramatic change post-integration most likely related to Oregon
laws enacted January 1, 2015 that allowed coverage for cross-sex hormone therapy, gender
reassignment surgery, and puberty suppression for individuals suffering from gender dysphoria
(Oregon Health Authority [OHA], 2015). Changes to insurance status noted a decrease (17.6%)
in uninsured/self-pay and an overall increase (16.7%) in Medicaid (7.0%), Medicare (3.6%), and
private insurance (6.1%). See Table 3, Population Characteristics Pre-and Post-integration.
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Preventive Health Screenings:
A Chi-Square Test of Association (significance level = 0.05) was performed to determine
if a relationship existed between the independent variable of gender-affirming services integrated
into primary care and the dependent variables representing preventive health screenings (cervical
cancer, depression, BMI, HTN, HIV, and tobacco use screenings).
See Table 4. Chi-Square Test Pre/Post Integration vs. Preventive Health Screenings.

Results indicated that a strong correlation existed between integration and tobacco use
screening (p<0.001). Of the 860 patients who met inclusive criteria and accessed care after
integration (July 1, 2015), 831 (96.6%) were screened for tobacco use as compared to 52
(29.9%) patients screened for tobacco use prior to integration. This positive association was
confirmed by a large Chi-Square value (X²=519.639) and a high strength of association (Phi =
0.709). A similar result was noted with cervical cancer screening (p=0.022). Of the 485 patients
who met inclusive criteria and were biologically a female at birth, 142 (35.9%) received a
Papanicolaou (PAP) test for cervical cancer screening after integration. Pre-integration noted
only 21 (23.3%) patients out of 90 receiving a Pap test prior to integration. The positive
association was confirmed by a Chi-Square value (X²=5.229) and a positive strength of
association (Phi= 0.104).
Depression screening (p<0.001) results noted a lower (54.3%) screening rate postintegration than in those patients who accessed care pre-integration (86.9%). This negative
correlation of depression screening and the integration of gender-affirming services in primary
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care is further evident by a negative statistical association (Phi = -0.250), but with a p<0.001 and
a moderate Chi-Square value (64.518).
HIV Screening noted a slight increase (37.6%) in screening rates post-integration as
compared to screening rates (32.6%) prior to integration. The Chi value (X²=1.566) indicates a
slight degree of association which is also noted in the Phi (Phi=0.39) and probability (p(0.212) <
α(0.05)) of obtaining a similar affect and speak to a positive correlation between integration and
improved health screenings.
BMI Screening, much like Tobacco use screening, showed a significant increase (95.7%)
post-integration as compared to pre-integration BMI screening results (1.1%). The Chi value
(X²=803.802), a p value (p<0.001), and a Phi (0.881) all confirm the significant correlation
between improvement in preventive health screenings and utilization of primary care resources
when inclusive services are integrated into primary care.
HTN screening, much like depression screening, showed a slight decrease (95.1%) postintegration as compared to screening rates pre-integration (97.1%). The probability value
(p=0.240) remains less than the set significant level (α) of 0.05. A negative Phi (-0.036) and a
small Chi test value (X²=1.378) indicate a negative correlation of HTN screenings and
integration.
Discussion
The goal of this project was to examine preventive healthcare screenings before and after
integration of inclusive gender-affirming services into primary care. Findings from this project
will be used to identify clinical practices and guidelines that can be enhanced through quality
improvement efforts for the TGNC population accessing healthcare at Outside In. The agency
has served and supported the TGNC and other vulnerable populations throughout its long tenure

IMPROVING PRIMARY CARE UTILIZATION FOR TRANSGENDER

18

within the medical and social service communities in the Portland, Oregon area. The decision to
end the well-established “Trans-Clinic” and move the gender-affirming services into primary
care was an operational decision and not a decision made from a quality improvement lens
Prior to the integration of gender-affirming services into primary care, a plan was
developed to educate medical providers, provide support and training to support and frontline
staff. Medical providers from the local community held trainings and provided consulting for
medical providers uncomfortable with caring for TGNC patients. Trans 101 trainings were
provided to the entire clinic staff from local community partners and Outside In’s Transgender
Coordinator. Medical Assistants and Nursing staff received specific trainings from Outside In’s
trans-identified medical assistants and the Transgender Coordinator. These trainings were
specifically geared towards understanding sources of trauma TGNC patients may experience in
the exam room and during medical procedures. What wasn’t done prior to and after integration
was a plan to circle back, after-integration, to determine if integration was successful and how
Outside In could improve health outcomes and services for the TGNC patient population. This
project is the first look at the effects of the integration in terms of how Outside In’s TGNC
patients are utilizing primary care services by comparing the rates of preventive health
screenings.
A significant change, noted soon after integration took place, was a sharp increase in the
number of new TGNC patients accessing care at Outside In. The integration and the improved
effort to provide inclusive care to all patients opened access to important healthcare for a
population riddled with health disparities. Findings from this project confirm that integration of
TGNC services into primary care can increase the volume of TGNC patients seeking primary
care, thus improving access for this population.
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Other questions to answer regarding the integration: Are TGNC patients utilizing primary
care services and how can Outside In improve care and positively effect health outcomes? The
project started out defining the utilization of primary care services by looking at preventive
health screening rates. The screenings chosen were the top screenings that were noted to be
important to Outside In primary care providers: cervical cancer, tobacco use, and depression
screenings. In obtaining the screening data, HIV, BMI, and HTN screenings data was also
obtained thus included as measures in this project.
BMI screening rates were the most remarkable with increase (95.7%) post-integration as
compared to pre-integration (1.1%). BMI calculations require both a height and a weight. With
such a large range being reported, it is possible that the GE Centricity system did not calculate
BMI if a height isn’t input at the time of the visit with the weight. For instance, if the height
used for the visit was a previously recorded height, the BMI would not have been recorded. All
patients, both cis-gender and TGNC, should be screened for BMI. An elevated BMI is a risk
factor for the development of cardiovascular disease (CVD) and/or diabetes (Schmidt & Rizzolo,
2017).
Ensuring that TGNC patients are routinely screened for tobacco use is a critical first step
in linking patients to tobacco cessation programs. Butchting et al., noted several recent studies
have reported that TGNC tobacco use rates are often higher than rates noted in the LGB and Cisgendered populations, with Trans-women (TW) having even higher rates than Trans-men(TM)
(Buchting et al., 2017). The importance of tobacco use screening and follow-up is increasingly
important in TGNC patients who choose to access cross-sex hormone therapy, especially for
TW. Studies monitoring TW have noted the occurrence of venous thromboembolism with the
use of estrogen therapy (Meyers & Safer, 2017). Data from this project noted a significant
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increase in tobacco use screening post-integration (96.6%) as compared to pre-integration
(29.7%). What could not be determined from the data, however, is the percentage of patients
reported tobacco use and the percentage that were referred to smoking cessation programs.
Tobacco use screening and follow-up is a quality measurement that is actively being monitored
not only at Outside In, but also at the Federal and State levels. At the Federal level, the agencies
are: Centers for Medicare & Medicaid Services (CMS), Health Resources & Safety
Administration (HRSA), National HIV & AIDS Bureau, and the National Committee for Quality
Assurance (NCQA). At the State level: Accountable Care and Coordinated Care Organizations,
and State Health Departments or Departments of Human Services.
Not only is it important to ensure patients are provided support and education regarding
tobacco use, this measure is one that is often a source of revenue for improved outcomes.
Outside In participates in a quality improvement incentive program sponsored by the
Coordinated Care Organizations (CCOs) that oversee Medicaid. This program requires a
quarterly 3% improvement on pre-selected clinical quality measures (CQMs). Meeting the
improvement benchmarks would mean a pre-determined per member per month (PMPM) rate for
all Medicaid patients assigned to Outside In, whether they are engaged in care or not. Meeting
these benchmarks can mean a sizable incentive every month. An assumption can be made that
the large increase in screening rates occurring post-integration was due to robust workflows and
mindfulness towards this quality metric from administration down to the medical assistants. This
may not have been a source of focus for “Trans-Clinic” providers and staff.
The cervical cancer screening rates noted post-integration (35.9%) as compared to the
screening rates pre-integration (23.3%) was higher than expected. Outside In has long struggled
with moving cervical cancer screening rates for cis-gender women to the 40% mark and beyond.
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Several different workflows have been attempted to change this quality metric. However, the
needle rarely moves with this CQM. Recently, Outside In is stepping up the outreach to patients
by using volunteers to contact patients via phone or through the patient portal, MyChart, in order
to schedule a preventive screening appointment which would include a PAP test.
A cervical cancer screening rate of 36% for our TM population mirrors Outside In’s
current cervical cancer screening rates for the cis-gender women at Outside In. Prior studies have
reported significantly lower cervical cancer screening rates among TM when compared to other
sexual-minority (lesbians) and cis-gender women. One study noted that FTM patients had a 37%
lower screening rate than that of non-FTM patients (Peitzmeier, Khullar, Reisner, & Potter,
2014). Findings from our study suggests that creating a welcoming, safe, and inclusive
environment may have a positive impact on improved healthcare utilization of TGNC patients,
including cervical cancer screenings in trans-male patients.
A systematic review of HIV prevalence and risk factors of transgender persons in the US
found that TGNC populations have higher rates of HIV infection and engage in high levels of
risky behavior (Herbst et al., 2008). HIV screening rates at Outside In increased slightly postintegration. It’s difficult to determine if there is a strong association between increased HIV
screening and inclusive, gender-affirming services being integrated into primary care. Given the
increased risk for TGNC populations, further quality improvement efforts are recommended.
The two areas of notable surprise were depression screening and HTN screening results.
Like Tobacco use screening, these are areas that are tracked and are often tied to a revenue
source if quality metrics improve. Given that TGNC populations have an increased risk for
mental health issues and suicidality – it will be important to work on improving workflows for
both metrics to improve health outcomes for this population.
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The overall results of this quality improvement project successfully noted that four of the
six preventive health screenings showed a positive association between the integration of
inclusive gender-affirming services into primary care and did affect the rate at which preventive
screenings were utilized by TGNC patients accessing primary care services at Outside In. More
significantly, the project also revealed an impressive uptake in access for TGNC patients. The
overall success not only provided valuable information on the successful results and processes in
place, but also pointed to areas such as improving depression screening rates, HTN screening
rates, and ensuring that Outside In is maximizing its efficiency in promoting the health and wellbeing of its TGNC populations.
Study Limitations
Findings must be considered within the context of the study’s limitations. First, this QI project
used a single, study site. Therefore, findings from this study may not be generalized or relevant
to other FQHCs. Moreover, by design, QI projects do not control for extraneous variables and
cannot establish cause and effect relationships (Shirey et al., 2011). Therefore, one cannot
accurately conclude that changes in screening rates were due to the policy changes at the clinic.
Despite these limitations, other FQHCs and primary care sites may benefit from
knowledge gained and lessons learned at Outside In because of this project. Additionally,
findings from this project can be used to inform QI efforts and future research opportunities.
Implications/Recommendations for Practice, Policy, and Research
Implications and recommendations for the TGNC population on a large scale should
begin with improved training of our current and future medical providers, frontline staff, support
staff, and lawmakers. Altering medical curriculum to include education on sexual and gender
minorities, the effects of stigmatization of marginalized populations on health outcomes, and the
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importance of social determinants of health. Ensuring that medical providers, specifically
primary care medical providers, are knowledgeable in gender-affirming healthcare and issues
affecting the TGNC population will aid in improving provider-patient relationships Thus,
decreasing the barriers to accessing healthcare based on fear of discrimination and increasing
access to safe and quality care.
Lawmakers and leaders within communities and governments should work on
incentivizing primary care healthcare facilities and providers for providing safe and genderaffirming services within primary care based on improvement on quality metrics that are
inclusive to TGNC patients. Often community health clinics, rural clinics, and FQHCs receive
incentives and funding sources to specifically improve health outcomes for certain populations
(diabetics, high emergency department utilizers, homeless, etc). Providing incentives would
provide an opportunity for increased access to primary care practices that would be providing
inclusive care.
A large barrier to on-going research for the TGNC population is the inability to collect
accurate and meaningful data. Lawmakers community leaders, and leaders in healthcare should
ensure that government and community surveys include questions inclusive to the TGNC
populations. Healthcare systems should also incorporate appropriate fields on applications and
within registration fields to assist in accurately identifying members of the TGNC populations.
Research for the TGNC population is important as the state of the science in this area is
still emerging and the amount of research available is minimal. Increasing research on the effects
of trauma and stigmatization/discrimination of this population will shed light on the TGNC
population and help inform our understanding of disparities seen in other marginalized
populations.
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Findings from this project will help inform quality improvement initiatives in other
clinics and health facilities that serve TGNC populations. Findings from this project will also
help inform future larger scale projects and research studies for TGNC populations.
Conclusion
As noted previously, the TGNC populations are one of the most marginalized populations
in the U.S. They endure significant barriers to housing, employment, education, and healthcare.
The multiple layers of stigmatization faced by this population create negative psychosocial
conditions that result in adverse health outcomes and exposure to chronic physiological stress
(White, Reisner, & Pachankis, 2015). Sustained stress levels in individuals have immediate
negative effects on the body and can compromise health over time (White, Reisner, & Pachankis,
2015). For instance, chronic stress can lead to obesity, diabetes, hypertension, anxiety,
depression, and suicidality. Multiple layers of stigma and discrimination further exacerbate these
conditions by causing TGNC people to delay or avoid healthcare, adds to their distrust of the
medical system, and creates social conditions which lead to risk-taking behaviors and poor
health.
The aim of the project was to identify clinical practices and guidelines that can be
enhanced through quality improvement efforts for the TGNC populations accessing primary care
at an FQHC. The success of this project is a first step in addressing barriers related to
stigmatization/discrimination by providing a safe and inclusive environment that supports the
TGNC population in achieving improved health.
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Tables
Table 1. Identifying and Defining Variables
Variables

Theoretical Definition

Integration of
Transgender genderaffirming services
into primary care
services.
Utilization of primary
care services

Moving longstanding
transgender clinic and
integrating all genderaffirming services into
primary care.
TGNC patients utilizing
preventive health services.

Preventive Health
services accessed

TGNC patients utilizing
preventive health services.

Demographic
Patients 18+

Adult patients

Age 18+

Sex at Birth

Birth Sex

Male, Female, Other in registration

Ethnicity

Field in EHR

Race

Field in EHR

Gender Identification Field in EHR
Preferred Pronoun

Annotated in EHR

Insurance Status

Verified

Operational Definition
Gender-affirming care:
• Hormone services
• Referrals for surgery letters
• Referrals for surgical services
Comparing the following:
• DOS
• ICD9/10 codes
• Chief complaint
Comparing rates of preventive health
services:
• Cervical CA screenings
o PAP
• Tobacco use screening
• Depression screening
o PHQ2
o PHQ9
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Table 2. Inclusive Billing Codes and Descriptive Definition
Inclusive
Codes
ICD-9
256.39

Code Description

257.2

Other testicular hypofunction

259.9

Unspecified endocrine disorder

302.0

Sexual & gender identity disorders

302.3

Transvestic fetishism

302.5

Trans-sexualism

302.50

Trans-sexualism with unspecified sexual history

302.51

Trans-sexualism with a sexual history

302.52

Trans-sexualim with homosexual history

302.53

Trans-sexualism with heterosexual history

302.85

Gender identity disorder in adolescents or adults

302.89

Other specified psychosexual disorders

302.9

Unspecified psychosexual disorder

309.9

Unspecified adjustment reaction

752.7

Indeterminate sex and pseudohermaphrodism

Other ovarian failure

ICD-10
E28.39

Other primary ovarian failure

E29.1

Testicular hypofunction

E34.9

Endocrine disorder, unspecified

F43.20

Adjustment disorder, unspecified

F52.9

Psychosexual dysfunction unspecified

F64.0

Transsexualism

F64.1

Dual-role transvestism

F64.8

Other gender identity disorder
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F64.9

Gender identity disorder, unspecified

F65.1

Transvestic fetishism

F65.81

Other specified psychosexual disorders

F66

Other sexual disorders

Q56.3

Pseudohermaphroditism, unspecified

Q56.4

Indeterminate sex, unspecified

Z87.890

Personal history of sex reassignment

Modifiers
45

Ambiguous Gender Category Claim indicates patient had ambiguous gender characteristics transgendered or hermaphrodite (Department of Health & Human Services [DHHS], 2009, p. 13)

KX

Modifier used with procedure codes that are gender specific when patient is transgender,
ambiguous genitalia, or hermaphrodite patients.
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Table 3. Population Characteristics Pre- and Post-integration
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Table 4. Chi-Square Test Pre/Post Integration vs. Preventive Health Screenings
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